{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T08:03:09Z","timestamp":1793347389207,"version":"4.5.0"},"reference-count":65,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T00:00:00Z","timestamp":1727136000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010663","name":"European Research Council","doi-asserted-by":"publisher","award":["833247"],"award-info":[{"award-number":["833247"]}],"id":[{"id":"10.13039\/100010663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010663","name":"European Research Council","doi-asserted-by":"publisher","award":["948207"],"award-info":[{"award-number":["948207"]}],"id":[{"id":"10.13039\/100010663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010665","name":"EU Framework Programme for Research and Innovation Marie Sk\u0142odowska-Curie Actions","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003246","name":"Nederlandse Organisatie voor Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006209","name":"Radboud Universitair Medisch Centrum","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006209","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018693","name":"Horizon Europe","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018693","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.jinf.2024.106300","type":"journal-article","created":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T18:46:19Z","timestamp":1727721979000},"page":"106300","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Regulation of plasma soluble receptors of TNF and IL-1 in patients with COVID-19 differs from that observed in sepsis"],"prefix":"10.1016","volume":"89","author":[{"given":"Muhammed D.","family":"Aksu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tijmen","family":"van der Ent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenhua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anca L.","family":"Riza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aline H.","family":"de Nooijer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isis","family":"Rica\u00f1o-Ponce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nico","family":"Janssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Job J.","family":"Engel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioana","family":"Streata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helga","family":"Dijkstra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidi","family":"Lemmers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inge","family":"Grondman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerie A.C.M.","family":"Koeken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleni","family":"Antoniadou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7552-5878","authenticated-orcid":false,"given":"Nikolaos","family":"Antonakos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank L.","family":"van de Veerdonk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evangelos J.","family":"Giamarellos-Bourboulis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihai G.","family":"Netea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athanasios","family":"Ziogas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.jinf.2024.106300_bib1","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/nri.2017.36","article-title":"The immunopathology of sepsis and potential therapeutic targets","volume":"17","author":"van der Poll","year":"2017","journal-title":"Nat Rev Immunol"},{"issue":"8","key":"10.1016\/j.jinf.2024.106300_bib2","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"issue":"10219","key":"10.1016\/j.jinf.2024.106300_bib3","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0140-6736(19)32989-7","article-title":"Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the Global Burden of Disease Study","volume":"395","author":"Rudd","year":"2020","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.jinf.2024.106300_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ofid\/ofy313","article-title":"Sepsis\u00a0in intensive care unit patients: worldwide data from the intensive care over nations audit","volume":"5","author":"Sakr","year":"2018","journal-title":"Open Forum Infect Dis"},{"issue":"8","key":"10.1016\/j.jinf.2024.106300_bib5","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1007\/s00134-020-06151-x","article-title":"Incidence and mortality of hospital- and ICU-treated sepsis: results from an updated and expanded systematic review and meta-analysis","volume":"46","author":"Fleischmann-Struzek","year":"2020","journal-title":"Intens Care Med"},{"issue":"10223","key":"10.1016\/j.jinf.2024.106300_bib6","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.jinf.2024.106300_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0235458","article-title":"Clinical characteristics of 82 cases of death from COVID-19","volume":"15","author":"Zhang","year":"2020","journal-title":"Plos One"},{"issue":"6","key":"10.1016\/j.jinf.2024.106300_bib8","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1007\/s00134-020-06028-z","article-title":"Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China (vol 17, pg 851, 2020)","volume":"46","author":"Ruan","year":"2020","journal-title":"Intens Care Med"},{"issue":"12","key":"10.1016\/j.jinf.2024.106300_bib9","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1097\/CCM.0000000000005195","article-title":"Coronavirus disease 2019 as cause of viral sepsis: a systematic review and meta-analysis","volume":"49","author":"Karakike","year":"2021","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jinf.2024.106300_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2020.01446","article-title":"The COVID-19 cytokine storm; what we know so far","volume":"11","author":"Ragab","year":"2020","journal-title":"Front Immunol"},{"issue":"5","key":"10.1016\/j.jinf.2024.106300_bib11","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s00281-017-0639-8","article-title":"Cytokine storm and sepsis disease pathogenesis","volume":"39","author":"Chousterman","year":"2017","journal-title":"Semin Immunopathol"},{"issue":"17","key":"10.1016\/j.jinf.2024.106300_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1172\/jci.insight.140289","article-title":"Cytokine profile in plasma of severe COVID-19 does not differ from ARDS and sepsis","volume":"5","author":"Wilson","year":"2020","journal-title":"Jci Insight"},{"issue":"6","key":"10.1016\/j.jinf.2024.106300_bib13","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1002\/art.40071","article-title":"Cytokine storm syndrome: looking toward the precision medicine era","volume":"69","author":"Behrens","year":"2017","journal-title":"Arthritis Rheumatol"},{"issue":"2","key":"10.1016\/j.jinf.2024.106300_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.ppat.1000661","article-title":"IL-1 betaprocessing in host defense: beyond the inflammasomes","volume":"6","author":"Netea","year":"2010","journal-title":"Plos Pathog"},{"key":"10.1016\/j.jinf.2024.106300_bib15","first-page":"1","article-title":"Susceptibility to Intracellular Infections: contributions of TNF to Immune Defense","volume":"11","author":"Li","year":"2020","journal-title":"Front Microbiol"},{"key":"10.1016\/j.jinf.2024.106300_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2013\/165974","article-title":"Cytokines in sepsis: potent immunoregulators and potential therapeutic targets\u2014an updated view","volume":"2013","author":"Schulte","year":"2013","journal-title":"Mediat Inflamm"},{"issue":"10235","key":"10.1016\/j.jinf.2024.106300_bib17","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1016\/S0140-6736(20)30920-X","article-title":"SARS-CoV-2 and viral sepsis: observations and hypotheses","volume":"395","author":"Li","year":"2020","journal-title":"Lancet"},{"issue":"157","key":"10.1016\/j.jinf.2024.106300_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1183\/16000617.0038-2020","article-title":"Respiratory viral sepsis: epidemiology, pathophysiology, diagnosis and treatment","volume":"29","author":"Gu","year":"2020","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.jinf.2024.106300_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cyto.2022.156006","article-title":"Proinflammatory cytokines levels in sepsis and healthy volunteers, and tumor necrosis factor-alpha associated sepsis mortality: a systematic review and meta-analysis","volume":"158","author":"Gharamti","year":"2022","journal-title":"Cytokine"},{"issue":"10","key":"10.1016\/j.jinf.2024.106300_bib20","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1038\/s41591-020-1051-9","article-title":"An inflammatory cytokine signature predicts COVID-19 severity and survival","volume":"26","author":"Del Valle","year":"2020","journal-title":"Nat Med"},{"issue":"9","key":"10.1016\/j.jinf.2024.106300_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/jcm10092017","article-title":"HGF, IL-1alpha, and IL-27 are robust biomarkers in early severity stratification of COVID-19 patients","volume":"10","author":"Tamayo-Velasco","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.jinf.2024.106300_bib22","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/2755246","article-title":"Associations between serum interleukins (IL-1beta, IL-2, IL-4, IL-6, IL-8, and IL-10) and disease severity of COVID-19: a systematic review and meta-analysis","volume":"2022","author":"Chang","year":"2022","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.jinf.2024.106300_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fcell.2019.00091","article-title":"TNFR1 and TNFR2 in the control of the life and death balance of macrophages","volume":"7","author":"Wajant","year":"2019","journal-title":"Front Cell Dev Biol"},{"issue":"10","key":"10.1016\/j.jinf.2024.106300_bib24","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/s41584-019-0277-8","article-title":"The IL-1 family of cytokines and receptors in rheumatic diseases","volume":"15","author":"Dinarello","year":"2019","journal-title":"Nat Rev Rheumatol"},{"issue":"5120","key":"10.1016\/j.jinf.2024.106300_bib25","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1126\/science.8332913","article-title":"Interleukin-1 type-II receptor \u2013 a decoy target for Il-1 that is regulated by Il-4","volume":"261","author":"Colotta","year":"1993","journal-title":"Science"},{"issue":"9","key":"10.1016\/j.jinf.2024.106300_bib26","doi-asserted-by":"crossref","first-page":"5343","DOI":"10.4049\/jimmunol.173.9.5343","article-title":"Mechanisms of soluble cytokine receptor generation","volume":"173","author":"Levine","year":"2004","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.jinf.2024.106300_bib27","first-page":"251","article-title":"The role of soluble receptors in cytokine biology: the agonistic properties of the sIL-6R\/IL-6 complex","volume":"1592","author":"Jones","year":"2002","journal-title":"Bba-Mol Cell Res"},{"issue":"1","key":"10.1016\/j.jinf.2024.106300_bib28","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/imr.12606","article-title":"The family of the interleukin-1 receptors","volume":"281","author":"Boraschi","year":"2018","journal-title":"Immunol Rev"},{"issue":"3","key":"10.1016\/j.jinf.2024.106300_bib29","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S1359-6101(96)00026-3","article-title":"The potential biological and clinical significance of the soluble tumor necrosis factor receptors","volume":"7","author":"Aderka","year":"1996","journal-title":"Cytokine Growth Factor Rev"},{"issue":"11","key":"10.1016\/j.jinf.2024.106300_bib30","article-title":"Toward personalized immunotherapy in sepsis: the PROVIDE randomized clinical trial","volume":"3","author":"Leventogiannis","year":"2022","journal-title":"Cell Rep Med"},{"key":"10.1016\/j.jinf.2024.106300_bib31","article-title":"Targeting TNF-alpha for COVID-19: recent advanced and controversies","volume":"10","author":"Guo","year":"2022","journal-title":"Front Public Health"},{"issue":"7","key":"10.1016\/j.jinf.2024.106300_bib32","doi-asserted-by":"crossref","first-page":"E393","DOI":"10.1016\/S2665-9913(20)30164-8","article-title":"Anakinra for severe forms of COVID-19: a cohort study","volume":"2","author":"Huet","year":"2020","journal-title":"Lancet Rheumatol"},{"issue":"10","key":"10.1016\/j.jinf.2024.106300_bib33","doi-asserted-by":"crossref","first-page":"E690","DOI":"10.1016\/S2665-9913(21)00216-2","article-title":"Effect of anakinra on mortality in patients with COVID-19: a systematic review and patient-level meta-analysis","volume":"3","author":"Kyriazopoulou","year":"2021","journal-title":"Lancet Rheumatol"},{"issue":"4","key":"10.1016\/j.jinf.2024.106300_bib34","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1111\/ijcp.12382","article-title":"Anti-TNF-alpha therapy for patients with sepsis: a systematic meta-analysis","volume":"68","author":"Lv","year":"2014","journal-title":"Int J Clin Pract"},{"issue":"8","key":"10.1016\/j.jinf.2024.106300_bib35","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1093\/infdis\/jiab065","article-title":"Dysregulated innate and adaptive immune responses discriminate disease severity in COVID-19","volume":"223","author":"Janssen","year":"2021","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.jinf.2024.106300_bib36","doi-asserted-by":"crossref","first-page":"E97","DOI":"10.1148\/radiol.2020201473","article-title":"CO-RADS: a categorical CT assessment scheme for patients suspected of having COVID-19 definition and evaluation","volume":"296","author":"Prokop","year":"2020","journal-title":"Radiology"},{"issue":"4","key":"10.1016\/j.jinf.2024.106300_bib37","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1097\/01.CCM.0000050454.01978.3B","article-title":"2001 SCCM\/ESICM\/ACCP\/ATS\/SIS International Sepsis Definitions Conference","volume":"31","author":"Levy","year":"2003","journal-title":"Crit Care Med"},{"issue":"1","key":"10.1016\/j.jinf.2024.106300_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12879-022-07761-0","article-title":"Characterization of sepsis inflammatory endotypes using circulatory proteins in patients with severe infection: a prospective cohort study","volume":"22","author":"Ricano-Ponce","year":"2022","journal-title":"Bmc Infect Dis"},{"issue":"7","key":"10.1016\/j.jinf.2024.106300_bib39","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1097\/01.CCM.0000168253.91200.83","article-title":"The international sepsis forum consensus conference on definitions of infection in the intensive care unit","volume":"33","author":"Calandra","year":"2005","journal-title":"Crit Care Med"},{"issue":"10","key":"10.1016\/j.jinf.2024.106300_bib40","doi-asserted-by":"crossref","first-page":"5591","DOI":"10.1172\/JCI133935","article-title":"BCG vaccination in humans inhibits systemic inflammation in a sex-dependent manner","volume":"130","author":"Koeken","year":"2020","journal-title":"J Clin Invest"},{"issue":"6","key":"10.1016\/j.jinf.2024.106300_bib41","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/j.cell.2020.08.001","article-title":"Severe COVID-19 is marked by a dysregulated myeloid cell compartment","volume":"182","author":"Schulte-Schrepping","year":"2020","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.jinf.2024.106300_bib42","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s15010-020-01464-x","article-title":"Studying the pathophysiology of coronavirus disease 2019: a protocol for the Berlin prospective COVID-19 patient cohort (Pa-COVID-19)","volume":"48","author":"Kurth","year":"2020","journal-title":"Infection"},{"issue":"13","key":"10.1016\/j.jinf.2024.106300_bib43","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","article-title":"Integrated analysis of multimodal single-cell data","volume":"184","author":"Hao","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.jinf.2024.106300_bib44","article-title":"Single-cell transcriptomics identifies different immune signatures between macrophage activation-like syndrome and immune paralysis in sepsis","volume":"2023","author":"Grondman","year":"2023","journal-title":"medRxiv"},{"issue":"2","key":"10.1016\/j.jinf.2024.106300_bib45","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1586\/14737159.8.2.189","article-title":"Cytokines and their receptors as biomarkers of systemic lupus erythematosus","volume":"8","author":"Suh","year":"2008","journal-title":"Expert Rev Mol Diagn"},{"key":"10.1016\/j.jinf.2024.106300_bib46","first-page":"1","article-title":"Circulating TNF receptors 1 and 2 predict mortality in patients with end-stage renal disease undergoing dialysis","volume":"7","author":"Gohda","year":"2017","journal-title":"Sci Rep-Uk"},{"key":"10.1016\/j.jinf.2024.106300_bib47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphar.2021.656928","article-title":"Serum soluble tumor necrosis factor receptors 1 and 2 are early prognosis markers after ST-segment elevation myocardial infarction","volume":"12","author":"Paccalet","year":"2021","journal-title":"Front Pharmacol"},{"issue":"10","key":"10.1016\/j.jinf.2024.106300_bib48","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0275745","article-title":"Circulating tumor necrosis factor receptors are associated with mortality and disease severity in COVID-19 patients","volume":"17","author":"Gohda","year":"2022","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.jinf.2024.106300_bib49","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1093\/infdis\/jiaa744","article-title":"Levels of soluble CD14 and tumor necrosis factor receptors 1 and 2 may be predictive of death in severe coronavirus disease 2019","volume":"223","author":"Bowman","year":"2021","journal-title":"J Infect Dis"},{"issue":"16","key":"10.1016\/j.jinf.2024.106300_bib50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms22168423","article-title":"Severe COVID-19 patients show an increase in soluble TNFR1 and ADAM17, with a relationship to mortality","volume":"22","author":"Palacios","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.jinf.2024.106300_bib51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13054-020-03166-0","article-title":"Blocking IL-1 to prevent respiratory failure in COVID-19","volume":"24","author":"van de Veerdonk","year":"2020","journal-title":"Crit Care"},{"key":"10.1016\/j.jinf.2024.106300_bib52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ebiom.2022.104299","article-title":"Interleukin-1 and the NLRP3 inflammasome in COVID-19: Pathogenetic and therapeutic implications","volume":"85","author":"Potere","year":"2022","journal-title":"Ebiomedicine"},{"key":"10.1016\/j.jinf.2024.106300_bib53","first-page":"1","article-title":"Microarray analysis identifies IL-1 receptor type 2 as a novel candidate biomarker in patients with acute respiratory distress syndrome","volume":"16","author":"Kovach","year":"2015","journal-title":"Resp Res"},{"key":"10.1016\/j.jinf.2024.106300_bib54","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.cytogfr.2020.04.003","article-title":"Biological functions and therapeutic opportunities of soluble cytokine receptors","volume":"55","author":"Lokau","year":"2020","journal-title":"Cytokine Growth F R"},{"issue":"1","key":"10.1016\/j.jinf.2024.106300_bib55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-020-17834-w","article-title":"Single-cell analysis of two severe COVID-19 patients reveals a monocyte-associated and tocilizumab-responding cytokine storm","volume":"11","author":"Guo","year":"2020","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.jinf.2024.106300_bib56","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/s41590-020-00840-x","article-title":"Untuned antiviral immunity in COVID-19 revealed by temporal type I\/III interferon patterns and flu comparison","volume":"22","author":"Galani","year":"2021","journal-title":"Nat Immunol"},{"issue":"2","key":"10.1016\/j.jinf.2024.106300_bib57","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1084\/jem.172.2.599","article-title":"Shedding of tumor necrosis factor receptors by activated human neutrophils","volume":"172","author":"Porteu","year":"1990","journal-title":"J Exp Med"},{"issue":"1","key":"10.1016\/j.jinf.2024.106300_bib58","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1189\/jlb.0307193","article-title":"Role of ADAM17 in the ectodomain shedding of TNF-alpha and its receptors by neutrophils and macrophages","volume":"82","author":"Bell","year":"2007","journal-title":"J Leukoc Biol"},{"issue":"361","key":"10.1016\/j.jinf.2024.106300_bib59","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.2005548","article-title":"Shedding of the tumor necrosis factor (TNF) receptor from the surface of hepatocytes during sepsis limits inflammation through cGMP signaling","volume":"8","author":"Deng","year":"2015","journal-title":"Sci Signal"},{"key":"10.1016\/j.jinf.2024.106300_bib60","doi-asserted-by":"crossref","first-page":"138","DOI":"10.3389\/fcimb.2017.00138","article-title":"Ectodomain shedding by ADAM17: its role in neutrophil recruitment and the impairment of this process during sepsis","volume":"7","author":"Mishra","year":"2017","journal-title":"Front Cell Infect Microbiol"},{"issue":"4","key":"10.1016\/j.jinf.2024.106300_bib61","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1159\/000447830","article-title":"Association study between promoter polymorphisms of ADAM17 and progression of sepsis","volume":"39","author":"Shao","year":"2016","journal-title":"Cell Physiol Biochem"},{"issue":"12","key":"10.1016\/j.jinf.2024.106300_bib62","doi-asserted-by":"crossref","first-page":"5802","DOI":"10.4049\/jimmunol.153.12.5802","article-title":"Elevated levels of shed type-II Il-1 receptor in sepsis - potential role for type-II receptor in regulation of Il-1 responses","volume":"153","author":"Giri","year":"1994","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.jinf.2024.106300_bib63","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/SHK.0000000000000714","article-title":"Interleukin-1 receptor 2: a new biomarker for sepsis diagnosis and Gram-negative\/Gram-positive bacterial differentiation","volume":"47","author":"Lang","year":"2017","journal-title":"Shock"},{"issue":"3","key":"10.1016\/j.jinf.2024.106300_bib64","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/BF01793854","article-title":"Pattern of soluble TNF receptor-I and receptor-II in sepsis","volume":"23","author":"Schroder","year":"1995","journal-title":"Infection"},{"issue":"11","key":"10.1016\/j.jinf.2024.106300_bib65","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1097\/00003246-199811000-00016","article-title":"Use of the SOFA score to assess the incidence of organ dysfunction\/failure in intensive care units: Results of a multicenter, prospective study","volume":"26","author":"Vincent","year":"1998","journal-title":"Crit Care Med"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445324002342?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445324002342?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T23:14:10Z","timestamp":1744154050000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445324002342"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":65,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S0163445324002342"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2024.106300","relation":{},"ISSN":["0163-4453"],"issn-type":[{"value":"0163-4453","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Regulation of plasma soluble receptors of TNF and IL-1 in patients with COVID-19 differs from that observed in sepsis","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2024.106300","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd on behalf of The British Infection Association.","name":"copyright","label":"Copyright"}],"article-number":"106300"}}